Sarah E. Davis

1.1k total citations
29 papers, 841 citations indexed

About

Sarah E. Davis is a scholar working on Molecular Biology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sarah E. Davis has authored 29 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Infectious Diseases and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sarah E. Davis's work include HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Sarah E. Davis is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Sarah E. Davis collaborates with scholars based in United States, United Kingdom and Botswana. Sarah E. Davis's co-authors include Aseem Z. Ansari, Robert Landick, Rachel A. Mooney, Sylvia Frisancho‐Kiss, Noel R. Rose, Daniela Čiháková, Jason M. Peters, Masheka A. Barrett, DeLisa Fairweather and Jennifer L. Rowland and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Sarah E. Davis

27 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah E. Davis United States 12 397 206 185 133 103 29 841
Shuhua Ma China 19 400 1.0× 161 0.8× 103 0.6× 50 0.4× 99 1.0× 67 1.1k
Katherine B. Hisert United States 14 429 1.1× 372 1.8× 118 0.6× 81 0.6× 541 5.3× 23 1.3k
Xingyun Wang China 22 675 1.7× 118 0.6× 61 0.3× 54 0.4× 174 1.7× 87 1.3k
Julie Wilhelmy United States 15 455 1.1× 194 0.9× 113 0.6× 22 0.2× 59 0.6× 24 1.0k
Sarah Johnson United States 17 401 1.0× 109 0.5× 135 0.7× 24 0.2× 53 0.5× 52 861
S. Heyder Germany 7 519 1.3× 92 0.4× 127 0.7× 25 0.2× 136 1.3× 10 1.4k
Christopher R. Bailey United States 22 640 1.6× 101 0.5× 131 0.7× 28 0.2× 128 1.2× 63 1.5k
Komei Shirabe Japan 22 379 1.0× 111 0.5× 80 0.4× 134 1.0× 310 3.0× 63 1.4k
Allison R. Rogala United States 14 368 0.9× 61 0.3× 261 1.4× 44 0.3× 57 0.6× 19 805

Countries citing papers authored by Sarah E. Davis

Since Specialization
Citations

This map shows the geographic impact of Sarah E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Davis more than expected).

Fields of papers citing papers by Sarah E. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Davis. The network helps show where Sarah E. Davis may publish in the future.

Co-authorship network of co-authors of Sarah E. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Davis. A scholar is included among the top collaborators of Sarah E. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Davis. Sarah E. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Davis, Sarah E., Omar Moukha‐Chafiq, Sixue Zhang, et al.. (2024). Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIV. Journal of Pharmacology and Experimental Therapeutics. 392(2). 100021–100021.
3.
Davis, Sarah E., et al.. (2023). The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases. International Journal of Molecular Sciences. 24(20). 15340–15340. 27 indexed citations
4.
Davis, Sarah E., Mark J. Ferris, Subramaniam Ananthan, Corinne E. Augelli‐Szafran, & Jun Zhu. (2022). Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice. Journal of Pharmacology and Experimental Therapeutics. 384(2). 306–314. 7 indexed citations
5.
Quizon, Pamela M., Sarah E. Davis, Yaxia Yuan, et al.. (2022). Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. PLoS ONE. 17(9). e0275182–e0275182. 5 indexed citations
6.
Hoggard, Lori S., et al.. (2022). “Now I just need something sweet”: Racism, emotional eating, and health among African Americans. Social Science & Medicine. 316. 114947–114947. 10 indexed citations
7.
Davis, Sarah E. & Jun Zhu. (2022). Substance abuse and neurotransmission. Advances in pharmacology. 93. 403–441. 5 indexed citations
8.
Davis, Sarah E., et al.. (2020). Enhancement of fast scan cyclic voltammetry detection of dopamine with tryptophan-modified electrodes. PLoS ONE. 15(7). e0235407–e0235407. 5 indexed citations
9.
Ceddia, Ryan P., Ryan D. Morrison, Sarah E. Davis, et al.. (2019). The effect of the EP3 antagonist DG-041 on male mice with diet-induced obesity. Prostaglandins & Other Lipid Mediators. 144. 106353–106353. 10 indexed citations
10.
Chvála, O., et al.. (2019). Genetic Algorithm Design of a Coupled Fast and Thermal Subcritical Assembly. Nuclear Technology. 206(4). 609–619. 13 indexed citations
11.
Park, Yoon‐Dong, Joseph N Jarvis, Guowu Hu, et al.. (2018). Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence. mBio. 9(6). 4 indexed citations
12.
Duckworth, Robert, et al.. (2018). Mechanical and Chemical Properties of Harvested Hypalon Cable Jacket Subjected to Accelerated Thermal Aging. Nuclear Technology. 202(2-3). 124–131. 1 indexed citations
13.
Buxton, Meredith, Angela DeMichele, Jane Perlmutter, et al.. (2014). Transforming the clinical trial process: The I-SPY 2 trial as a model for improving the efficiency of clinical trials and accelerating the drug-screening process.. Journal of Clinical Oncology. 32(15_suppl). TPS2633–TPS2633. 2 indexed citations
14.
Sarode, Neha, et al.. (2013). The Wsc1p Cell Wall Signaling Protein Controls Biofilm (Mat) Formation Independently of Flo11p in Saccharomyces cerevisiae. G3 Genes Genomes Genetics. 4(2). 199–207. 9 indexed citations
15.
16.
Mooney, Rachel A., Sarah E. Davis, Jason M. Peters, et al.. (2009). Regulator Trafficking on Bacterial Transcription Units In Vivo. Molecular Cell. 33(1). 97–108. 193 indexed citations
17.
Bröer, Angelika, et al.. (2009). Sodium translocation by the iminoglycinuria associated imino transporter (SLC6A20). Molecular Membrane Biology. 26(5-7). 333–346. 15 indexed citations
18.
Frisancho‐Kiss, Sylvia, Sarah E. Davis, Jennifer F. Nyland, et al.. (2007). Cutting Edge: Cross-Regulation by TLR4 and T cell Ig Mucin-3 Determines Sex Differences in Inflammatory Heart Disease. The Journal of Immunology. 178(11). 6710–6714. 161 indexed citations
19.
Frisancho‐Kiss, Sylvia, Jennifer F. Nyland, Sarah E. Davis, et al.. (2006). Cutting Edge: T Cell Ig Mucin-3 Reduces Inflammatory Heart Disease by Increasing CTLA-4 during Innate Immunity. The Journal of Immunology. 176(11). 6411–6415. 117 indexed citations
20.
Lü, Zhen, Steven P. Rowe, Sarah E. Davis, et al.. (2005). Unraveling the Mechanism of a Potent Transcriptional Activator. Journal of Biological Chemistry. 280(33). 29689–29698. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuhua Ma Breakdown of academic impact, for papers by Katherine B. Hisert Breakdown of academic impact, for papers by Xingyun Wang Breakdown of academic impact, for papers by Julie Wilhelmy Breakdown of academic impact, for papers by Sarah Johnson Breakdown of academic impact, for papers by S. Heyder Breakdown of academic impact, for papers by Christopher R. Bailey Breakdown of academic impact, for papers by Komei Shirabe Breakdown of academic impact, for papers by Allison R. Rogala
Rankless by CCL
2026